Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BRIGHTPATH-BIOTHERAPEUTIC-24003791/news/GreenPeptide-Co-Ltd-Announces-Notice-of-Initiation-of-Phase-II-Clinical-Trial-of-GRN-1201-35217180/?utm_source=whatsapp&utm_medium=social&utm_campaign=share